Company

Synthetica Bio, Inc.

Synthetica Bio develops generative AI products that provide data and insights for biopharmaceutical teams.

About

Synthetica Bio develops generative AI products for clinical and commercial teams in the biopharmaceutical industry, including access to real-time data streams. Founded in 2023 in California by Simon Arkell and Alex Dickinson, the company raised USD 1.33 million in seed funding in June 2023, led by Virtue Venture Management, AIX Ventures, and PageOne.vc.

1Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in